Gwacheon-si, South Korea

Heun-Soo Kang


Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Heun-Soo Kang: Innovator in Immunological Therapeutics

Introduction

Heun-Soo Kang is a prominent inventor based in Gwacheon-si, South Korea. He is known for his significant contributions to the field of immunology, particularly through his innovative patent related to double-targeting antibodies.

Latest Patents

Heun-Soo Kang holds a patent for an "Anti-TNF-α/CXCL10 double-targeting antibody and use thereof." This invention focuses on a bispecific antibody that effectively binds to both TNF-α (tumor necrosis factor-alpha) and CXCL10 (C-X-C motif chemokine 10). The antibody is designed to have excellent inhibitory activity against TNF-α and osteoclast differentiation, making it a promising candidate for the prevention and treatment of immunological diseases.

Career Highlights

Heun-Soo Kang is associated with Metabolic Engineering Laboratories Co., Ltd., where he continues to advance research in immunological therapeutics. His work has the potential to significantly impact the treatment of various immunological conditions.

Collaborations

Heun-Soo Kang collaborates with notable colleagues, including So-Hyun Park and Yeong Wook Song, contributing to a dynamic research environment focused on innovative solutions in immunology.

Conclusion

Heun-Soo Kang's innovative work in developing double-targeting antibodies showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in the treatment of immunological diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…